Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Total Liabilities (2019 - 2025)

Volitionrx (VNRX) has disclosed Total Liabilities for 9 consecutive years, with $42.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Liabilities rose 20.04% year-over-year to $42.4 million, compared with a TTM value of $42.4 million through Sep 2025, up 20.04%, and an annual FY2024 reading of $35.5 million, down 3.15% over the prior year.
  • Total Liabilities was $42.4 million for Q3 2025 at Volitionrx, up from $41.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $42.4 million in Q3 2025 and bottomed at -$31.2 million in Q1 2021.
  • Average Total Liabilities over 5 years is $23.4 million, with a median of $21.4 million recorded in 2022.
  • The sharpest move saw Total Liabilities plummeted 505.26% in 2021, then soared 166.98% in 2022.
  • Year by year, Total Liabilities stood at $9.8 million in 2021, then skyrocketed by 119.3% to $21.4 million in 2022, then skyrocketed by 71.15% to $36.7 million in 2023, then dropped by 3.15% to $35.5 million in 2024, then grew by 19.41% to $42.4 million in 2025.
  • Business Quant data shows Total Liabilities for VNRX at $42.4 million in Q3 2025, $41.8 million in Q2 2025, and $37.5 million in Q1 2025.